LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Rituximab with High-Dose Methotrexate in Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2018.02.006
|
Citation:
|
LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Rituximab with High-Dose Methotrexate in Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2018.02.006
|
LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Rituximab with High-Dose Methotrexate in Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2018.02.006
|
Citation:
|
LI Ya-jun, LIU Yu-ting, ZHOU Hui, GUO Han-guo. Rituximab with High-Dose Methotrexate in Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2018.02.006
|
DownLoad: